<PAGE> 1
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------
FORM 10-K/A
(Mark One)
[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 1999
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from ____________ to ____________
Commission file number: 0-29818
LIFEPOINT HOSPITALS, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware 52-2165845
(State or Other Jurisdiction of (I.R.S. Employer
Incorporation or Organization) Identification No.)
103 Powell Court, Suite 200 37027
Brentwood, Tennessee (Zip Code)
(Address Of Principal Executive Offices)
Registrant's Telephone Number, Including Area Code: (615) 372-8500
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act:
<TABLE>
<CAPTION>
Title of Each Class Name of Each Exchange on Which Registered
------------------- -----------------------------------------
<S> <C>
Common Stock, par value $.01 per share The Nasdaq National Market System
Preferred Stock Purchase Rights The Nasdaq National Market System
</TABLE>
Indicate by check mark whether the registrant: (1) has filed all
reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes [X] No [ ]
Indicate by check mark if disclosure of delinquent filers pursuant to
Item 405 of Regulation S-K is not contained herein, and will not be contained,
to the best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. [X]
The aggregate market value of the shares of Common Stock (based upon
the closing sale price of these shares on March 17, 2000) of LifePoint
Hospitals, Inc. held by non-affiliates on March 17, 2000, was approximately
$378,056,672.
As of March 17, 2000, the number of outstanding shares of Common Stock
of LifePoint Hospitals, Inc. was 33,704,040.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of LifePoint's definitive Proxy Statement for its Annual
Meeting of Stockholders to be held on May 11, 2000 are incorporated by reference
into Part III hereof.
<PAGE> 2
EXPLANATORY NOTE
This amendment to the Annual Report on Form 10-K of LifePoint Hospitals,
Inc. for the fiscal year ended December 31, 1999 is being filed solely to
correct an inadvertant error which occurred upon filing of the Form 10-K. The
Financial Data Schedule originally filed as Exhibit 27 on behalf of LifePoint
Hospitals, Inc. contained information relating to LifePoint Hospitals Holdings,
Inc. The LifePoint Hospitals, Inc. Financial Data Schedule, as corrected, is
contained in this amendment.
<PAGE> 3
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report, as amended, to
be signed on its behalf by the undersigned, thereunto duly authorized, in the
City of Brentwood, State of Tennessee, on April 4, 2000.
LifePoint Hospitals, Inc.
By: /s/ Scott L. Mercy
-----------------------------------
Scott L. Mercy
Chairman and
Chief Executive Officer
<PAGE> 4
EXHIBIT INDEX
<TABLE>
<CAPTION>
Exhibit No. Description
----------- -----------
<S> <C>
27 - Financial Data Schedule for LifePoint Hospitals, Inc. (for SEC use only)
</TABLE>
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE FOR LIFEPOINT HOSPITALS, INC. CONTAINS SUMMARY FINANCIAL
INFORMATION EXTRACTED FROM THE STATEMENTS OF INCOME AND BALANCE SHEETS AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> DEC-31-1999
<PERIOD-START> JAN-01-1999
<PERIOD-END> DEC-31-1999
<CASH> 12,500
<SECURITIES> 0
<RECEIVABLES> 97,000
<ALLOWANCES> 50,300
<INVENTORY> 14,300
<CURRENT-ASSETS> 99,400
<PP&E> 492,800
<DEPRECIATION> 198,400
<TOTAL-ASSETS> 420,400
<CURRENT-LIABILITIES> 57,200
<BONDS> 257,100
0
0
<COMMON> 300
<OTHER-SE> 85,400
<TOTAL-LIABILITY-AND-EQUITY> 420,400
<SALES> 0
<TOTAL-REVENUES> 515,200
<CGS> 0
<TOTAL-COSTS> 281,600
<OTHER-EXPENSES> 117,300
<LOSS-PROVISION> 38,200
<INTEREST-EXPENSE> 23,400
<INCOME-PRETAX> (10,100)
<INCOME-TAX> (2,700)
<INCOME-CONTINUING> (7,400)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (7,400)
<EPS-BASIC> (0.24)<F1>
<EPS-DILUTED> (0.24)<F2>
<FN>
<F1>EPS - BASIC PER SFAS NO. 128
<F2>EPS - DILUTED PER SFAS NO.128
</FN>
</TABLE>
